Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Am J Med Genet A. 2010 Jan;152A(1):212–214. doi: 10.1002/ajmg.a.33166

Table I.

Summary of Cancer Types Reported in t(11;22) Carriers

Type of
Cancer
Number of
Reported
Male
Carriers
(average age
at diagnosis)
Expected
(male)
p-value
(male)
Number of
Reported
Female
Carriers
(average age
at diagnosis)
Expected
(female)
p-value
(female)
Expected
(male +
female)
p-value
Breast 0 0.013 1 2 (40.5) 3.34 0.51 - -
Prostate 2 (70) 1.59 0.69 n/a n/a n/a n/a n/a
Colorectal 0 - - 2 (82.5) - - 1.28 0.50
Esophageal 2 (72) - - 0 - - 0.13 0.008
Renal 1 (48) - - 0 - - 0.42 0.41
Uterine n/a n/a n/a 1 (45) 0.45 0.44 n/a n/a
Ovarian n/a n/a n/a 1 (55) 0.28 0.28 n/a n/a
Cervical n/a n/a n/a 1 (73) 0.28 0.28 n/a n/a
Leukemia 0 - - 1 (16) - - 0.48 0.47
Melanoma 1 (72) - - 2 (42.5) - - 0.63 0.03

U.S. age- and gender-specific cancer incidence rates [United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2008] were used to compute an expected incidence for each cancer type. The expected and observed numbers of each cancer type were compared and a mid-P exact test [Rothman and Boice, 1979] was used to generate p-values. P-values that reached statistical significance are italicized. n/a= not applicable.